AKEBIA THERAPEUTICS INC shareholders Q2 2023

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

AKEBIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TD Waterhouse Canada Inc. 40,553$45,7430.00%
ROYAL BANK OF CANADA 500$00.00%
Allworth Financial LP 748$6850.00%
BALDWIN BROTHERS LLC/MA 561$5130.00%
VANGUARD GROUP INC 7,811,061$7,147,1210.00%
Focused Wealth Management, Inc 65$590.00%
First Horizon Advisors, Inc. 5,600$5,1240.00%
JANE STREET GROUP, LLC 57,111$52,2570.00%
Capital Advisors, Ltd. LLC 320$00.00%
RAYMOND JAMES & ASSOCIATES 11,602$10,6160.00%
UBS Group AG 71,488$65,4120.00%
RHUMBLINE ADVISERS 4,926$4,5070.00%
NewEdge Advisors, LLC 2,535$2,3200.00%
PRUDENTIAL FINANCIAL INC 47,509$43,4710.00%
BNP PARIBAS FINANCIAL MARKETS 8,683$7,9450.00%
TWO SIGMA INVESTMENTS, LP 216,213$197,8350.00%
OSAIC HOLDINGS, INC. 739$6760.00%
FMR LLC 613,590$561,4350.00%
FIFTH THIRD BANCORP 3,300$3,0200.00%
FRANKLIN RESOURCES INC 82,473$75,4630.00%
External links

This page lists AKEBIA THERAPEUTICS INC's shareholders in Q2 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.